Access unparalleled healthcare datasets to develop your financial models and investment
strategies.
90B+
Total Claim Events
330M+
Unique Medical & Pharma Patients
500K+
Total Number of Unique Organizations
2.7M+
Total Number of Unique Providers
90K+
Total Number of Unique Diagnosis
1.5K+
Medical & Pharma Tickers Mapped
4K+
Pharma Manufacturers
11+
Years of Historical Data
Research
Use healthcare data to run effective finance models.
SEAMLESS
Integrates with your workflow
Our data experts work with you closely, delivering case study analytics that sync
effortlessly with your existing setup
ASSISTANT
Analysis for pros: IMX-Ray
AI designed to free financial professionals from routine tasks, so they can focus on
what matters — insights, models, and building products
Scalable
Capital efficient
Large datasets coupled with expert analysis at cost-effective prices
Speed
Daily, transparent delivery
Delays are costly. Realize unbiased insights months ahead of the competition
Limitless
Build models big and small
Don’t get stuck in noisy data. Clear inputs for solutions from bespoke to large
scale
CASE STUDIES
Real data. Real insights.
HEALTHCARE
GLP-1 Drug Market Analysis
Quarterly claims data reveals the explosive growth of GLP-1 drugs — who's
prescribing, who's paying, and where the market is heading.
In a concerning trend, a growing number of older adults find themselves compelled to
make agonizing choices, sacrificing fundamental necessities to cope with the
escalating burden of healthcare costs.
Quarterly claims data reveals the explosive growth of ADC Oncology drugs — who's
prescribing, who's paying, and where the market is heading.
In a concerning trend, a growing number of older adults find themselves compelled to
make agonizing choices, sacrificing fundamental necessities to cope with the
escalating burden of healthcare costs.
Access the full interactive walkthrough in desktop view.
"For too long, healthcare data has been scattered and siloed. We’re here to clear the
data fog and give finance experts a clear path to unlocking its potential. This is the
vision guiding my team."
Jim Plante CEO
Frequently Asked Questions
Everything you need to know about IMX Data
Healthcare claims data built for institutional investors, hedge funds, and quant funds.
Can't find what you're looking for? Contact us.
SOC 2 Type II Certified
All data de-identified per HIPAA Safe Harbor (45 CFR 164.514(b)). SOC 2 Type II
certified in 2025.Enterprise-grade security and compliance for institutional clients.